Event Type: The company will participate in an investor conference featuring 1x1 meetings with Franklin Templeton.
Date and Time: The meeting is scheduled for Friday, August 14, 2026, at 11:00 AM IST.
Mode of Meeting: The interaction will be conducted virtually.
Management Participants: The company will be represented by Mr. Amit Bakshi and Mr. Krishnakumar Vaidyanathan from Franklin Templeton (note: these appear to be fund representatives, not Eris management). The disclosure does not specify which Eris Lifesciences management personnel will participate.
UPSI Statement: The company explicitly states that "no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction." The company will refer only to publicly available documents for discussions.
Schedule Nature: The disclosure notes that the schedule is "indicative and is subject to changes necessitated by any unforeseen developments."
Additional Notes
Regulatory Basis: This intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Financial Data: No financial data, results, guidance, or strategic updates were disclosed in this announcement.
Attachments: No attachments such as presentation decks or detailed schedules were mentioned in this disclosure.
Compliance Officer: The disclosure was signed by Milind Talegaonkar, Company Secretary & Compliance Officer (Membership No: A26493).
